Search research articles
Contact Us
Filters
Showing results (261-270 of 450) with videos related to
Page
of 45
Sort By:
Psychopharmacology
|
April 2, 2010
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
Christina L Nemeth, Tracie A Paine, Joseph E Rittiner, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor
Zhong Zheng, Xi-Ping Huang, Thomas J Mangano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2006
p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling
Douglas J Sheffler, Wesley K Kroeze, Bonnie G Garcia, et al.
ACS Chemical Biology
|
March 15, 2013
Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor
Dahlia R Weiss, SeungKirl Ahn, Maria F Sassano, et al.
Cell Reports
|
September 10, 2013
DREADDs in Drosophila: a pharmacogenetic approach for controlling behavior, neuronal signaling, and physiology in the fly
Jaime Becnel, Oralee Johnson, Zana R Majeed, et al.
Science Translational Medicine
|
May 8, 2024
MRGPRX4 mediates phospho-drug-associated pruritus in a humanized mouse model
Daphne Chun-Che Chien, Nathachit Limjunyawong, Can Cao, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist
F Ivy Carroll, Moses G Gichinga, John D Williams, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
September 19, 2003
Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands
Marco De Amici, Paola Conti, Ezio Fasoli, et al.
Molecular Pharmacology
|
July 17, 2008
New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug)
Vindhya Nawaratne, Katie Leach, Nur Suratman, et al.
The Journal of Biological Chemistry
|
October 15, 2013
Chemotype-selective modes of action of κ-opioid receptor agonists
Eyal Vardy, Philip D Mosier, Kevin J Frankowski, et al.
Page
of 45
Search research articles
Search
Showing results (261-270 of 450) with videos related to
Sort By:
Page
of 45
Psychopharmacology
|
April 2, 2010
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
Christina L Nemeth, Tracie A Paine, Joseph E Rittiner, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor
Zhong Zheng, Xi-Ping Huang, Thomas J Mangano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2006
p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling
Douglas J Sheffler, Wesley K Kroeze, Bonnie G Garcia, et al.
ACS Chemical Biology
|
March 15, 2013
Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor
Dahlia R Weiss, SeungKirl Ahn, Maria F Sassano, et al.
Cell Reports
|
September 10, 2013
DREADDs in Drosophila: a pharmacogenetic approach for controlling behavior, neuronal signaling, and physiology in the fly
Jaime Becnel, Oralee Johnson, Zana R Majeed, et al.
Science Translational Medicine
|
May 8, 2024
MRGPRX4 mediates phospho-drug-associated pruritus in a humanized mouse model
Daphne Chun-Che Chien, Nathachit Limjunyawong, Can Cao, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist
F Ivy Carroll, Moses G Gichinga, John D Williams, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
September 19, 2003
Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands
Marco De Amici, Paola Conti, Ezio Fasoli, et al.
Molecular Pharmacology
|
July 17, 2008
New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug)
Vindhya Nawaratne, Katie Leach, Nur Suratman, et al.
The Journal of Biological Chemistry
|
October 15, 2013
Chemotype-selective modes of action of κ-opioid receptor agonists
Eyal Vardy, Philip D Mosier, Kevin J Frankowski, et al.
Page
of 45